Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hyperion's Ravicti now available in U.S.

March 1, 2013

Korean group prepares novel 11-beta-HSD-1 inhibitors

March 1, 2013

Dainippon Sumitomo Pharma obtains additional indication approval for Surepost in Japan

March 1, 2013

Vildagliptin approval expanded in Japan

March 1, 2013

Benet Tablets 75 mg available in Japan

Feb. 28, 2013

Clinical trial data presented for taliglucerase alfa in patients with Gaucher's disease

Feb. 28, 2013

FDA stops pediatric trials of Sensipar

Feb. 28, 2013

FDA approves Osphena for the treatment of dyspareunia

Feb. 27, 2013

Amarin files sNDA for Vascepa

Feb. 27, 2013

Psyadon enrolls first patients in phase III study of ecopipam in Lesch-Nyhan disease

Feb. 27, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...